EUVIMEDEUVIMED entdecken
Crossref

Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration

Rimsha Maqsood, Areeba Mushtaq, Kainat Nawaz, Ezza Ikram, Abdul Ghaffar Majeed

INNOVAPATH · 22.06.2026 · 2 (2) · 5

DOI: 10.63501/azz6za12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INNOVAPATH, online erschienen am 22.06.2026. Verfasst von Rimsha Maqsood und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microglial activation and sustained neuroinflammation are central features of chronic neurodegenerative diseases. Emerging evidence indicates that microglial function is tightly linked to intracellular metabolic state, with shifts between oxidative phosphorylation (OXPHOS) and glycolysis shaping inflammatory output, phagocytosis, and neurotoxicity.

Objective

To synthesize mechanistic, translational, and disease-specific evidence that positions microglial metabolic reprogramming as a key driver and potential therapeutic target in chronic neurodegeneration.

Methods

Narrative synthesis of preclinical and clinical studies addressing microglial metabolism, mitochondrial dysfunction, inflammasome activation, and immunometabolic interventions.

Findings

Pro-inflammatory stimuli (LPS, amyloid-β, α-synuclein) induce glycolytic reprogramming in microglia, accompanied by mitochondrial dysfunction, ROS generation, and NLRP3 inflammasome activation (3,6,9). Disease-specific evidence links these metabolic shifts to impaired debris clearance and sustained cytokine release in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and ALS (8,10–13). Aging-associated metabolic drift primes microglia toward inflammatory phenotypes (14). Interventions targeting glycolysis, AMPK activation, or NLRP3 show preclinical promise (3,6,16).

Conclusion

Microglial immunometabolism provides a mechanistic bridge between chronic inflammation and neurodegeneration. Precision metabolic modulation of microglia — recalibrating rather than suppressing activity — is a promising translational strategy warranting biomarker-guided clinical evaluation.

Zitieren

APA

Maqsood, R., Mushtaq, A., Nawaz, K., Ikram, E., & Majeed, A. G. (2026). Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration. INNOVAPATH, 2(2), 5. https://doi.org/10.63501/azz6za12

Vancouver

Maqsood R, Mushtaq A, Nawaz K, Ikram E, Majeed AG. Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration. INNOVAPATH. 2026;2(2):5. doi:10.63501/azz6za12

BibTeX
@article{Maqsood2026,
  author = {Maqsood, Rimsha and Mushtaq, Areeba and Nawaz, Kainat and Ikram, Ezza and Majeed, Abdul Ghaffar},
  title = {Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration},
  journal = {INNOVAPATH},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {5},
  doi = {10.63501/azz6za12}
}
Kostenlos starten →